Andy Gardiner

Andy Gardiner has held a variety of roles in the life sciences industry since 1997. Andy began their career as a Board Member at Prospero Biotech and went on to become an Associate at XOventure Life Science Experts in 2009. In 2008, they became the Managing Director of Verdant Venture Management, and in 2012, they were appointed Finance Director and Managing Director at Seven League. From 2009 to 2018, they served as a Board Member at Immudex AS and Co-Founder at Double Bio and Sundew ApS. In 2020, they joined the Founding team of Chosa Oncology, and in 2021 they joined the Founding team of Aida Oncology. In 2022, they joined the Founding team of Gly-it.

Andy Gardiner received their BSc in Physics from The University of Manchester between 1981 and 1984. Andy later went on to earn an MBA from London South Bank University between 1991 and 1994.